Abiopharma

🔍 Eun David (Director)

Company: Howard Hughes Holdings Inc. (HHH)

Report Date: 2026-06-19

Detailed Transactions and Holdings:

• Acquired 3,290 shares of Common stock, $0.01 par value (Direct)
  Date: 2026-06-19 | Code: A | equity_swap_involved: 0 | shares_owned_after: 9,720.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents restricted stock granted to non-employee directors pursuant to the Issuer's 2025 Equity Incentive Plan. The shares vest on the earlier of the 2027 annual meeting of stockholders of Howard Hughes Holdings Inc. or June 1, 2027.